Skin News and Research

RSS

Survival rates of nine types of cancer in Spain

Spanish epidemiologists have presented information on survival of nine types of cancer in Spain and have compared it with other European countries. At five years from diagnosis, the lowest survival rate is observed in lung cancer (less than 11%), and the highest in testicular cancer (95%). Cancer survival in Spain is at the European average.

16 Jul 2010

Innovative imaging system uses night vision technology to tackle common side effect of cancer treatment

The University of Texas Health Science Center at Houston (UTHealth) has reached an agreement with other institutions that will allow it to take the next step in commercially developing an innovative medical imaging system that uses night vision technology to tackle a common side effect of cancer treatment.

16 Jul 2010

Study results to help researchers better understand cancer genetics, improve treatment regimens

The largest study to correlate genetics with response to cancer drugs releases its first results today. The researchers behind the study, based at Massachusetts General Hospital Cancer Center and the Wellcome Trust Sanger Institute, describe in this initial dataset the responses of 350 cancer samples to 18 anticancer therapeutics.

16 Jul 2010

JDD publishes long-term efficacy and tolerability study of PyratineXR Moisturizing Lotion

The June 2010 issue of Journal of Drugs in Dermatology (JDD), a full-color, peer-reviewed publication serving the dermatology community, features a study on the long-term efficacy and tolerability of the active ingredient in PyratineXR™.

16 Jul 2010

NovaBay Pharmaceuticals issued Notice of Allowance for broad portfolio of anti-infective compounds

NovaBay Pharmaceuticals, Inc. announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office on a patent application for a broad portfolio of anti-infective compounds, including NVC-612. The patent will broaden protection for NovaBay's first-in-class Aganocide family of compounds, which are designed to fight infections without causing drug resistance.

15 Jul 2010

Premier, Xoft execute group purchasing contract

Premier Inc., an alliance of more than 2,300 U.S. hospitals and 67,000-plus other healthcare sites working together to achieve high quality, cost-effective care, and Xoft, Inc., the leading provider of FDA-cleared Electronic Brachytherapy Systems, announced the execution of a group purchasing contract. Xoft was awarded an exclusive three-year contract for brachytherapy systems with Premier Purchasing Partners L.P., the group purchasing unit of Premier, Inc.

15 Jul 2010

NIH announces 5 more years of funding for Consortium of Food Allergy Research

Today, the National Institutes of Health announce that the Consortium of Food Allergy Research (CoFAR), established in 2005, will be funded for five more years. CoFAR will continue to foster new approaches to prevent and treat food allergies and also expand in scope to include research on the genetic causes underlying food allergy and studies of food allergy-associated eosinophilic gastrointestinal diseases (EGIDs).

15 Jul 2010

Pennsylvanians should take steps to reduce exposure to mosquitoes, Secretary of Health advises

The Pennsylvania Department of Health reminds Pennsylvanians to take precautions to reduce exposure to mosquitoes as the season arrives for West Nile virus, or WNV, infections.

15 Jul 2010

SANUWAVE Health introduces orthoPACE device in Europe

SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, reports the European launch of the orthoPACE device intended for use in orthopedic, trauma and sports medicine indications following CE mark approval last month.

14 Jul 2010

Summer campaign to combat crimes against fashion, dangerous sunburn

FASHION-LOVING Brits have denounced 'socks and sandals' as the ultimate summer fashion faux pas, in a poll released today (13th July) to celebrate the launch of 'Fashion Forecast' from Cancer Research UK's SunSmart campaign and fashion retailer ASOS.com, which provides tailored online fashion advice to help people be stylish while avoiding sunburn this summer.

14 Jul 2010

Skin cell samples may help discover factors behind Parkinson's disease

Researchers are applying new stem cell technology to use skin samples to grow the brain cells thought to be responsible for the onset of Parkinson's disease

14 Jul 2010

Susceptibility to Behcet's disease associated with genes involved in body's immune response

Researchers with the National Institutes of Health have found susceptibility to Behcet's disease, a painful, inflammatory condition, to be associated with genes involved in the body's immune response.

14 Jul 2010

CMAJ publishes new, updated guidelines on vitamin D

New and updated guidelines on recommended vitamin D intake have been published this week in the online issue of the Canadian Medical Association Journal.

14 Jul 2010

Fredericksburg Oncology invites participants for new metastatic melanoma clinical trial

Fredericksburg Oncology is now accepting patients for a new clinical trial supported by the National Cancer Institute (NCI) to evaluate treatment for metastatic (advanced stage) melanoma. The current trial, designed at the Mayo Clinic, combines chemotherapy with targeted molecular agents in an effort to improve control of this difficult disease, reports Dr. Frederick C. Tucker, Jr., who heads this practice.

13 Jul 2010

SCENESSE reduces, prevents phototoxic reactions experienced by EPP patients in Phase III trial

A new Australian drug has been shown to assist in protecting patients with a rare genetic disorder that makes their skin toxic to light and UV, and previously forced them to live in the shadows.

13 Jul 2010

Line of moisture absorber products available to eliminate dampness that enables mold to grow

The stifling humidity accompanying this summer's extreme temperatures increases the chance that homeowners will experience significant indoor humidity and moisture that may lead to musty odors, allergens, and mold and mildew that lead to or aggravate allergies, asthma and other health concerns and can even lead to structural damage.

13 Jul 2010

TLR7, TLR9 proteins could be culprit behind lupus patients' resistance to steroid treatments: Scientists

Two immune system proteins could be the culprit behind many lupus patients' resistance to widely used steroid treatments, scientists with the Baylor Research Institute in Dallas announced today. It is estimated that more than 5 million people suffer from lupus worldwide.

13 Jul 2010

MagnaCare social networking campaigns raise awareness of personal health, preventive care

MagnaCare, a health plan services company with national reach, today announces that its ongoing social networking campaigns are successfully raising awareness of the importance of personal health improvement and preventive care, emphasizing issues that sometimes fall between the cracks of larger causes, and advancing the MagnaCare commitment to "Care Right Here."

13 Jul 2010

Co-morbidities, socioeconomic status impact survival rates in colorectal cancer

Blacks are surviving colorectal cancer at a significantly lower rate compared to whites and Asians due to co-morbidities and their socioeconomic status, according to research by epidemiologists at The University of Texas Health Science Center at Houston.

13 Jul 2010

FRC refutes RCOG claims on fetal pain

The Family Research Council today released a new report that refutes claims made recently by the Royal College of Obstetricians and Gynaecologists' (RCOG) that a fetus is not able to feel pain before 24 weeks of development. RCOG's study is being used to uphold Britain's current legalization of abortions up to 24 weeks.

13 Jul 2010

Skin News and Research

Survival rates of nine types of cancer in Spain

Innovative imaging system uses night vision technology to tackle common side effect of cancer treatment

Study results to help researchers better understand cancer genetics, improve treatment regimens

JDD publishes long-term efficacy and tolerability study of PyratineXR Moisturizing Lotion

NovaBay Pharmaceuticals issued Notice of Allowance for broad portfolio of anti-infective compounds

Premier, Xoft execute group purchasing contract

NIH announces 5 more years of funding for Consortium of Food Allergy Research

Pennsylvanians should take steps to reduce exposure to mosquitoes, Secretary of Health advises

SANUWAVE Health introduces orthoPACE device in Europe

Summer campaign to combat crimes against fashion, dangerous sunburn

Skin cell samples may help discover factors behind Parkinson's disease

Susceptibility to Behcet's disease associated with genes involved in body's immune response

CMAJ publishes new, updated guidelines on vitamin D

Fredericksburg Oncology invites participants for new metastatic melanoma clinical trial

SCENESSE reduces, prevents phototoxic reactions experienced by EPP patients in Phase III trial

Line of moisture absorber products available to eliminate dampness that enables mold to grow

TLR7, TLR9 proteins could be culprit behind lupus patients' resistance to steroid treatments: Scientists

MagnaCare social networking campaigns raise awareness of personal health, preventive care

Co-morbidities, socioeconomic status impact survival rates in colorectal cancer

FRC refutes RCOG claims on fetal pain

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News